Presentation is loading. Please wait.

Presentation is loading. Please wait.

A) The World Health Organization (WHO) model of resource allocation in cancer care from 1990 depicting “present allocation of cancer resources” and “proposed.

Published byGarry Foster Modified over 5 years ago

Similar presentations

Presentation on theme: "A) The World Health Organization (WHO) model of resource allocation in cancer care from 1990 depicting “present allocation of cancer resources” and “proposed."— Presentation transcript:

1 a) The World Health Organization (WHO) model of resource allocation in cancer care from 1990 depicting “present allocation of cancer resources” and “proposed allocation of cancer resources in developed countries”. a) The World Health Organization (WHO) model of resource allocation in cancer care from 1990 depicting “present allocation of cancer resources” and “proposed allocation of cancer resources in developed countries”. Reproduced from [167] with permission from the publisher. b) WHO model of “continuum of care” in association with palliative care from 2002 [5]. Source: copyright of Education for Physicians on End-of-life Care (EPEC) Project, The Robert Wood Johnson Foundation, 1999 [168]. Reproduced and modified from [168] with permission from the publisher. c) Novel integrated lung cancer care concept with diagnostics, systemic therapy, radiotherapy, surgery, palliative care and follow-up as equitable pillars of lung cancer care. Torsten Blum, and Nicolas Schönfeld Eur Respir J 2015;45: ©2015 by European Respiratory Society

Download ppt "A) The World Health Organization (WHO) model of resource allocation in cancer care from 1990 depicting “present allocation of cancer resources” and “proposed."

Similar presentations

Tracy Costigan and Jennifer Ng’andu Robert Wood Johnson Foundation

Tracy Costigan and Jennifer Ng’andu Robert Wood Johnson Foundation
Quit rate (7-day point prevalence) for long-term nicotine replacement therapy users in the varenicline and placebo groups from weeks 2 to 52, verified.

Quit rate (7-day point prevalence) for long-term nicotine replacement therapy users in the varenicline and placebo groups from weeks 2 to 52, verified.
Chronic Obstructive Pulmonary Disease: An Evidence-Based Approach to Treatment With a Focus on Anticholinergic Bronchodilation  Nicholas J. Gross, MD,

Chronic Obstructive Pulmonary Disease: An Evidence-Based Approach to Treatment With a Focus on Anticholinergic Bronchodilation  Nicholas J. Gross, MD,
Disease progression is preceded by right ventricular remodelling, but not by changes in clinical parameters. Disease progression is preceded by right ventricular.

Disease progression is preceded by right ventricular remodelling, but not by changes in clinical parameters. Disease progression is preceded by right ventricular.
Decision tree of the FALLS protocol.

Decision tree of the FALLS protocol.
The effect of sequential addition of sildenafil to first-line epoprostenol on exercise capacity measured using 6-min walk distance (6MWD) in the PACES.

The effect of sequential addition of sildenafil to first-line epoprostenol on exercise capacity measured using 6-min walk distance (6MWD) in the PACES.
Plexiform lesion from a patient with severe pulmonary hypertension demonstrating the exuberant proliferation of cells that comprise the lumen of the small.

Plexiform lesion from a patient with severe pulmonary hypertension demonstrating the exuberant proliferation of cells that comprise the lumen of the small.
Integrated research framework, bounded by population and ecology of care axes running from highly selected to managed care populations (Y-axis) and from.

Integrated research framework, bounded by population and ecology of care axes running from highly selected to managed care populations (Y-axis) and from.
Level of physical activity by Global Initiative for Obstructive Lung Disease (GOLD) stage, BODE (body mass index, FEV1 for airflow obstruction, dyspnoea,

Level of physical activity by Global Initiative for Obstructive Lung Disease (GOLD) stage, BODE (body mass index, FEV1 for airflow obstruction, dyspnoea,
Forest plot showing the number of adults (at the top) and children (lower down) who were admitted to hospital after treatment in the emergency department.

Forest plot showing the number of adults (at the top) and children (lower down) who were admitted to hospital after treatment in the emergency department.
Treatment algorithm for managing chronic thromboembolic pulmonary hypertension (CTEPH), from the European Society of Cardiology/European Respiratory Society.

Treatment algorithm for managing chronic thromboembolic pulmonary hypertension (CTEPH), from the European Society of Cardiology/European Respiratory Society.
Kaplan–Meier analysis of survival over 2 years of treatment with riociguat in the CHEST-2 study [54]. Kaplan–Meier analysis of survival over 2 years of.

Kaplan–Meier analysis of survival over 2 years of treatment with riociguat in the CHEST-2 study [54]. Kaplan–Meier analysis of survival over 2 years of.
Extent of interstitial lung disease (ILD) in patients with systemic sclerosis-associated ILD. A simple stratification that utilises pulmonary function.

Extent of interstitial lung disease (ILD) in patients with systemic sclerosis-associated ILD. A simple stratification that utilises pulmonary function.
Representative diaphragm electromyogram (EMG) tracings at rest (a and b) and during maximum voluntary ventilation (c and d) in a healthy subject (a and.

Representative diaphragm electromyogram (EMG) tracings at rest (a and b) and during maximum voluntary ventilation (c and d) in a healthy subject (a and.
Schematic representations of alveolar units a) in health and b) in chronic obstructive pulmonary disease (COPD), and their corresponding flow versus volume.

Schematic representations of alveolar units a) in health and b) in chronic obstructive pulmonary disease (COPD), and their corresponding flow versus volume.
Smoking cessation rate as point prevalence quit rate from year 1 to 5 in the Lung Health Study with 5,587 chronic obstructive pulmonary disease patients.

Smoking cessation rate as point prevalence quit rate from year 1 to 5 in the Lung Health Study with 5,587 chronic obstructive pulmonary disease patients.
Changes in operating lung volumes are shown as ventilation increases with exercise in a) age-matched normal subjects (n = 25) and b) chronic obstructive.

Changes in operating lung volumes are shown as ventilation increases with exercise in a) age-matched normal subjects (n = 25) and b) chronic obstructive.
Patterns of p53 mutations according to smoking habits in a) all lung cancers minus nonsmokers (n = 1,289), b) smokers with lung cancer (n = 419), c) nonsmokers.

Patterns of p53 mutations according to smoking habits in a) all lung cancers minus nonsmokers (n = 1,289), b) smokers with lung cancer (n = 419), c) nonsmokers.
Effect of fibrinolysis on the empyema cavity size after VATS and open surgery. Effect of fibrinolysis on the empyema cavity size after VATS and open surgery.

Effect of fibrinolysis on the empyema cavity size after VATS and open surgery. Effect of fibrinolysis on the empyema cavity size after VATS and open surgery.
Probability of death as a function of the number of months after randomisation in the National Emphysema Treatment Trial comparing medical therapy (––––)

Probability of death as a function of the number of months after randomisation in the National Emphysema Treatment Trial comparing medical therapy (––––)

Similar presentations

Ads by Google